Sinemia faces consumer pushback and a class action suit over a battery of complaints

When Sinemiafirst came across our radar, the company was happily riding the wave of anti-MoviePass publicity. With its chief competition in the midst of what looked to be a historic collapse, Sinemia happily grabbed headlines as a what looked to be like a more stable alternative for movie ticket subscriptions.
Last July, at the height of MoviePass’meltdown, we asked Sinemia co-founder and CEO Rifat Oguz how he planned to avoid a similar fate. “By not providing unlimited tickets. But